172 related articles for article (PubMed ID: 10064173)
1. Autoimmune events during interferon beta-1b treatment for multiple sclerosis.
Durelli L; Ferrero B; Oggero A; Verdun E; Bongioanni MR; Gentile E; Isoardo GL; Ricci A; Rota E; Bergamasco B; Durazzo M; Saracco G; Biava MA; Brossa PC; Giorda L; Pagni R; Aimo G
J Neurol Sci; 1999 Jan; 162(1):74-83. PubMed ID: 10064173
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies in multiple sclerosis patients before and during IFN-beta 1b treatment: are they correlated with the occurrence of autoimmune diseases?
Verdun E; Isoardo G; Oggero A; Ferrero B; Ghezzi A; Montanari E; Zaffaroni M; Durelli L;
J Interferon Cytokine Res; 2002 Feb; 22(2):245-55. PubMed ID: 11911808
[TBL] [Abstract][Full Text] [Related]
3. Liver and thyroid function and autoimmunity during interferon-beta 1b treatment for MS.
Durelli L; Ferrero B; Oggero A; Verdun E; Ghezzi A; Montanari E; Zaffaroni M;
Neurology; 2001 Oct; 57(8):1363-70. PubMed ID: 11673572
[TBL] [Abstract][Full Text] [Related]
4. Interferon beta treatment for multiple sclerosis: persisting questions.
Goodkin DE
Mult Scler; 1996 Jul; 1(6):321-4. PubMed ID: 9345408
[TBL] [Abstract][Full Text] [Related]
5. Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study.
Durelli L; Oggero A; Verdun E; Isoardo GL; Barbero P; Bergamasco B; Brossa PC; Ghigo E; Maccario M; Faggiano F;
J Neurol Sci; 2001 Dec; 193(1):17-22. PubMed ID: 11718745
[TBL] [Abstract][Full Text] [Related]
6. Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis.
Uzawa A; Mori M; Hayakawa S; Masuda S; Kuwabara S
Eur J Neurol; 2010 May; 17(5):672-6. PubMed ID: 20039942
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of responders to interferon therapy for relapsing MS.
Waubant E; Vukusic S; Gignoux L; Dubief FD; Achiti I; Blanc S; Renoux C; Confavreux C
Neurology; 2003 Jul; 61(2):184-9. PubMed ID: 12874396
[TBL] [Abstract][Full Text] [Related]
8. Long-term interferon beta-1b therapy for MS: is routine thyroid assessment always useful?
Monzani F; Caraccio N; Casolaro A; Lombardo F; Moscato G; Murri L; Ferrannini E; Meucci G
Neurology; 2000 Aug; 55(4):549-52. PubMed ID: 10953190
[TBL] [Abstract][Full Text] [Related]
9. Severe liver dysfunction possibly caused by the combination of interferon beta-1b therapy and melilot (sweet clover) supplement.
Tamura S; Warabi Y; Matsubara S
J Clin Pharm Ther; 2012 Dec; 37(6):724-5. PubMed ID: 22642738
[TBL] [Abstract][Full Text] [Related]
10. Thyroid function and autoimmunity during interferon beta-1b treatment: a multicenter prospective study.
Durelli L; Ferrero B; Oggero A; Verdun E; Ghezzi A; Montanari E; Zaffaroni M;
J Clin Endocrinol Metab; 2001 Aug; 86(8):3525-32. PubMed ID: 11502774
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type.
Nikfar S; Rahimi R; Abdollahi M
Clin Ther; 2010 Oct; 32(11):1871-88. PubMed ID: 21095482
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody synthesis in primary progressive multiple sclerosis patients treated with interferon beta-1b.
Bitsch A; Dressel A; Meier K; Bogumil T; Deisenhammer F; Tumani H; Kitze B; Poser S; Weber F
J Neurol; 2004 Dec; 251(12):1498-501. PubMed ID: 15645350
[TBL] [Abstract][Full Text] [Related]
13. [Autoimmune functional disorders of the thyroid during interferon-beta-1b treatment in patients with multiple sclerosis. Case report and literature review].
Lange-Asschenfeldt C; Boor S; Kahaly GJ; Thömke F
Nervenarzt; 2004 Jun; 75(6):589-94. PubMed ID: 15257382
[TBL] [Abstract][Full Text] [Related]
14. Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.
Schippling S; O'Connor P; Knappertz V; Pohl C; Bogumil T; Suarez G; Cook S; Filippi M; Hartung HP; Comi G; Jeffery DR; Kappos L; Goodin DS; Arnason B
J Neurol; 2016 Jul; 263(7):1418-26. PubMed ID: 27177997
[TBL] [Abstract][Full Text] [Related]
15. Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).
Durelli L; Verdun E; Barbero P; Bergui M; Versino E; Ghezzi A; Montanari E; Zaffaroni M;
Lancet; 2002 Apr; 359(9316):1453-60. PubMed ID: 11988242
[TBL] [Abstract][Full Text] [Related]
16. Effect of 1-year treatment with interferon-beta1b on thyroid function and autoimmunity in patients with multiple sclerosis.
Monzani F; Caraccio N; Meucci G; Lombardo F; Moscato G; Casolaro A; Ferdeghini M; Murri L; Ferrannini E
Eur J Endocrinol; 1999 Oct; 141(4):325-31. PubMed ID: 10526243
[TBL] [Abstract][Full Text] [Related]
17. Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b.
Baum K; O'Leary C; Coret Ferrer F; Klímová E; Procházková L; Bugge J;
Mult Scler; 2007 Nov; 13(9):1153-60. PubMed ID: 17967843
[TBL] [Abstract][Full Text] [Related]
18. Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study.
Saida T; Tashiro K; Itoyama Y; Sato T; Ohashi Y; Zhao Z;
Neurology; 2005 Feb; 64(4):621-30. PubMed ID: 15728282
[TBL] [Abstract][Full Text] [Related]
19. Discordant effect of IFN-beta1a therapy on anti-IFN antibodies and thyroid disease development in patients with multiple sclerosis.
Monzani F; Meucci G; Caraccio N; Saviozzi M; Casolaro A; Moscato G; Lombardo F; Mosti S; Scagnolari C; Bruschi F; Antonelli G; Ferrannini E; Murri L
J Interferon Cytokine Res; 2002 Jul; 22(7):773-81. PubMed ID: 12184915
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune hemolytic anemia during interferon-beta-I b treatment for multiple sclerosis.
Alanoglu G; Kilbas S; Arslan C; Senol A; Kutluhan S
Mult Scler; 2007 Jun; 13(5):683-5. PubMed ID: 17548453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
